Human MenopausalGonadotrophin is a Medicine belongs to sex hormone group whose information about Brand can be referenced from   Book : Martindale    Page : 2317   Edition : 37, Martindale    Page : 2317   Edition : 37,

  ►   Brandname : Eventin,Pergonal,Menogon,Menopur,Merional,Humegon

  ►  Strength : Injection with   ,

Reference of this Medicine for its Strength can be taken from   Book : Martindale    Page : 2317   Edition : 37,
A Route of administration in pharmacology and toxicology is the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied. Common examples include oral and intravenous administration.

  ►  Route of administration : IM, SC,
Reference :-   Book : Martindale    Page : 2317   Edition : 37,

Dosing of Medicine differ in Adult & Pediatrics ↓


Adult Dose

S.No Ailment   Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency   Additional Info
1 Female infertility S.C/I.M 75 150 units Injection Dose: Given daily.
2 Male infertility S.C/I.M 75 150 units Injection bis in 7 d.
3 Male infertility S.C/I.M 75 150 units Injection t.i.w.

Ref :-  Book : Martindale    Page : 2317   Edition : 37,




Pediatric Dose

S.No Ailment   Age Min   Age Max   Weight ( Kg ) Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency  Additional Info  

Ref :- Book :
►  Side Effect : abdominal discomfort, abdominal pain, pleural effusion, Hypovolaemia, shock, fatalities, nausea, vomiting, joint pains, fever, Gynaecomastia, acne, weight gain, hypersensitivity reactions, local irritation at the injection site, thromboembolic disorders, ascites,
Ref :-   Book : Martindale    Page : 2316   Edition : 37,

►  Drug Interaction : Drug interaction of Human MenopausalGonadotrophin is with NA

  ►    Mechanism of Drug Drug Interaction :  In women who show evidence of excessive ovarian stimulation while receiving human menopausal gonadotrophins the use of drugs with luteinising-hormone (LH) activity increases the risk of ovarian hyperstimulation syndrome.,
Ref :-   Book : Martindale    Page : 2316   Edition : 37,


►  Contraindication : pregnancy, Pregnancy, Ovarian enlargement, Patients with abnormal genital bleeding, hormone sensitive malignancies such as those of the breast, uterus, prostate, ovaries or testes, or ovarian cysts or enlargement not caused by the polycystic ovary syndrome, Pituitary or hypothalamic lesions, adrenal or thyroid disorders, and hyperprolactinaemia should be treated appropriately to exclude them as causes of infertility before attempting therapy with human menopausal gonadotrophins,
Ref :-   Book : Martindale    Page : 2316   Edition : 37,
  ►  Mechanism of Action :   Human menopausal gonadotrophins possess both follicle- stimulating hormone (FSH) activity and luteinising hormone (LH) activity. Human menopausal gonadotrophins are given to induce follicular maturation and are followed by treatment with chorionic gonadotrophin to stimulate ovulation and corpus luteum formation.,
Ref :-   Book : Martindale    Page : 2316   Edition : 37,

Pathway of Dietry Product


​   ► Act.Comp / Nutrient / Food / Herb as follows :- NA


Dietry Substance Interactions


​   ► This Medicine interact with :- NA



ContraIndication Dietry Substance


​   ► This Medicine contraindicate with :- NA

►   Route of Elimination :   NA


►    Plasma Half-life :
  Min value :-   NA    Max value :-   NA


►    Peak Plasma Concentration :   Min value :-   NA    Max value :-   NA